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1875-9572/Copyright ª 2014, TaiwanInfantile systemic hyalinosis (ISH) is a rare multisystem fatal autosomal recessive disorder that
involves widespread deposition of hyaline on connective tissues and certain internal organs.
The major manifestations include painful articular contractures, hyperpigmentation, subcu-
taneous nodules, gingival hypertrophy, failure to thrive secondary to protein-losing enteropa-
thy, and osteolytic bone lesions. In this paper, we report a 12-month-old girl with ISH
presenting with recurrent diarrhea, failure to thrive, and refractory infections. A molecular
study identified a homozygous missense mutation, c.134T > C; p.L45P, in exon 1 of the anthrax
toxin receptor 2 (ANTRX2) gene. Our patient passed through an eventful course that included
septic shock, central line infections, right atrial thrombosis, and pericardial effusion. She
incurred acute bronchiolitis due to respiratory syncytial virus infection, which led to her death.
In conclusion, this case report highlights that severe and life-threatening morbidities and com-
plications can be encountered in ISH, to which some management options can be applied.
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Infantile systemic hyalinosis (ISH) [OMIM 236490] is a rare
autosomal recessive disorder that usually manifests in in-
fancy and leads to early childhood death.1,2 Infantile sys-
temic hyalinosis is characterized by widespread deposition
of hyaline, which may produce distinctive features of pro-
gressive joint contractures, skin papules, gingival hyper-
trophy, chronic diarrhea, and growth retardation.3,4mic Hyalinosis Complicated with Right Atrial Thrombus and Peri-
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secondary to impaired immunity.1,5 The gene responsible
for ISH has been mapped to chromosome 4q21.21. The
cause of ISH is mutations in the anthrax toxin receptor 2
(ANTRX2) gene, also known as the capillary morphogenesis
protein 2 (CMG2) gene.6 The purpose of this case report was
to highlight the severe and life-threatening morbidities and
complications encountered in ISH, to which some manage-
ment options can be applied.Figure 1 The electropherogram for the ANTXR2 gene muta-
tion c.134T > C; p.L45P.2. Case Report
A 12-month-old Saudi girl was born at full-term to a couple
who were second cousins. This couple has two other
healthy older children. There was no family history of birth
defects, learning difficulties, or genetic disorders. The in-
fant’s prenatal and neonatal history was unremarkable. Our
patient was delivered by spontaneous vaginal delivery. Her
birth weight was 2.1 kg (<3rd percentile), and her head
circumference and length were within the 25th percentile.
She was apparently normal at birth.
In the 2nd month of life, she appeared to have growth
retardation and required frequent hospitalizations for
hypoalbuminemia, dehydration, and recurrent infections
ranging from upper respiratory tract infection, pneumonia,
urinary tract infection, and gastroenteritis, to full-blown
septic shock. At the age of 4 months, she presented with
painful restriction of the upper and lower extremities at
several large and small joints. Despite aggressive physio-
therapy, joint contractures ineluctably emerged and
affected the large and small joints of the upper and lower
limbs. She also developed gum hypertrophy, small ear lobe
nodules, hyperpigmented macules on the bony promi-
nences, periosteal reaction in the long bones, and a peri-
anal fleshy mass. These symptoms and signs prompted us to
determine a diagnosis of ISH. The DNA from lymphocytes
was used to amplify the 17 coding exons and their corre-
sponding flanking sequences of the ANTXR2 gene. The po-
lymerase chain reaction (PCR) products were analyzed by
sequencing in the forward and reverse directions. Sequence
analysis identified a variant of a missense mutation,
c.134T > C; p.L45P, in exon 1 of the ANTRX2 gene. Serum
albumin was persistently low and the globulin level was
normal. A cause for the recurrent infections could not be
identified by extensive immunological workups, which
included immunoglobulins, complements, lymphocyte sub-
sets, T and B lymphocyte markers, and neutrophil
functions.
At 8 months of age, she presented with fever, diarrhea,
vomiting, and refusal to feed. She became severely ill and
dehydrated. Her albumin level was 6 g/L. She received
intravenous broad-spectrum antibiotics and albumin infu-
sion. One week later, a femoral central line was established
for the infusion of total parental nutrition (TPN). Two
weeks after central line insertion, our patient developed
central line infection that required another course of
broad-spectrum antibiotics. Echocardiography showed a
vegetation/clot extending from the inferior vena cava, the
right atrial junction, and the right atrium (Figure 1). How-
ever, the tip of the central line catheter was in the optimal
position in the inferior vena cava and not in direct contactPlease cite this article in press as: Mohamed S, et al., Infantile Syste
cardial Effusion in an Infant, Pediatrics and Neonatology (2014), http:with the right atrial wall. Prothrombin time, activated
partial prothrombin time, and international normalized
ratio were prolonged. Antithrombin II1, protein C, and
protein S levels were within normal limits. These coagula-
tion studies were compatible with disseminated intravas-
cular coagulopathy, which was treated with vitamin K,
fresh frozen plasma, and a continuous infusion of heparin.
She subsequently developed pericardial effusion (Figure 2).
Pericardiocentesis led to immediate hemodynamic
improvement. The aspirated fluid was chylous; it contained
normal protein and was free of red blood cells. She
remained in the pediatric intensive care unit (PICU) for 4
months, during which time the vegetative blood clot
enlarged progressively, despite vigorous administration of
intravenous heparin. She unfortunately experienced acute
bronchiolitis caused by respiratory syncytial virus infection
and required mechanical ventilation. She died because of
respiratory failure.3. Discussion
Infantile systemic hyalinosis is a rare autosomal recessive
disorder with a distinctive phenotype caused by mutations
in the ANTRX2 gene.1,6 Our patient manifested most char-
acteristic signs of ISH and had a homozygous missense
mutation of c.134T > C.1 This mutation predicts an amino
acid change of leucine to proline (p.L45P).1,6 Certain clin-
ical features of ISH, such as coarse facial features, gingival
hyperplasia, and progressive contractures, may resemble
features of lysosomal storage disorders such as Farber dis-
ease and mucolipidosis.7 Infantile systemic hyalinosis can
be differentiated from lysosomal storage disorders by themic Hyalinosis Complicated with Right Atrial Thrombus and Peri-
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Figure 2 Large circumferential pericardial effusion repre-
senting chylo-pericardium. LA Z left atrium; LV Z left
ventricle; PE Z pericardial effusion; RA Z right atrium;
RV Z right ventricle.
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index of suspicion is conducive to is needed for early
diagnosis of ISH. Recognition of subtle clinical clues in
affected individuals will help in planning relevant labora-
tory workups, managing associated morbidities, and
informing families of the grave outcome of ISH. There is no
effective treatment for ISH, although molecular diagnosis
may facilitate genetic counseling and prenatal diagnosis.
Furthermore, preimplantation genetic diagnosis can
potentially prevent the recurrence of the disease in future
pregnancies once the mutation has been established in the
proband.1
Patients with ISH are at high risk of infections. The
mechanism of recurrent infections is unclear. Some re-
ports suggest that patients with ISH have impaired immu-
nity.1,5 Klebanova et al5 reported a patient with ISH who
had combined immunodeficiency that was characterized
by low immunoglobulin G, poorly protective pneumococcal
titers, and impaired cellular immunity. Despite detailed
immunological tests, we could not identify any defect in
the immune system of our patient. Our patient had a
distinctive ISH phenotype; however, the unique finding was
intracardiac vegetative thrombosis, which may be attrib-
uted to sepsis and to protein-losing enteropathy.
Furthermore, the central venous catheter and the con-
tents of the TPN probably had a role in thrombus forma-
tion. The sluggish flow of the infusate may have
predisposed her to thrombosis. The indwelling catheter, by
being in persistent contact with the cardiac wall during
contractions, may activate coagulation cascades and lead
to thrombus formation.8,9 The other unusual manifestation
was pericardial effusion, which to our knowledge, has not
previously been reported in patients with ISH. ThePlease cite this article in press as: Mohamed S, et al., Infantile Syste
cardial Effusion in an Infant, Pediatrics and Neonatology (2014), http:pathophysiology of the chylopericardium associated with
ISH is unclear. It could be triggered by an inflammatory
response secondary to sepsis and disseminated intravas-
cular coagulopathy. The content of the pericardial aspi-
rate does not support direct infection of the pericardium.
The other mechanism of pericardial effusion could be
direct trauma to the pericardium.10e12 However, this is
unlikely because the tip of the central catheter was in the
optimal position and not in direct contact with the cardiac
wall. Furthermore, the pericardial effusion was free of red
blood cells. Considering that the pericardial aspirate was
initially chylous in character and later became a straw-
colored transudate, we deemed that the pericardial
effusion was related to central line infusion of TPN.8,10e12
Most patients with pericardial effusion resulting from
central line insertion reportedly do not show evidence of
trauma, which supports the hypothesis that pericardial
effusion occurs by osmotic diffusion of the TPN infusate
before overt myocardial perforation.8,10e12
The management of the intracardiac thrombus was
challenging. Its response to vitamin K, fresh frozen plasma,
and heparin infusion was suboptimal. The clot continued to
enlarge, despite all medical measures. Recombinant human
tissue type plasminogen activator is more clot-selective and
may represent a good alternative for thrombolytic treat-
ment; however, this drug was not available in our setting.13
The treatment options for a large intracardiac clot are
limited, after medical treatment failure.9 Cardiac catheter
intervention has a high risk of clot dislodgement because of
inferior vena caval manipulation, which may lead to a
pulmonary embolism.9,14
Open cardiac surgery was another alternative. Surgical
removal of an intracardiac thrombus has a high mortality
because of the need to use cardiopulmonary bypass, which
has its own complications.9,14 General anesthesia faces
potential difficulties with endotracheal intubation in pa-
tients with ISH, which increases the risk of perioperative
mortality. Special precautions during anesthesia in these
patients are of utmost importance. Pollard et al15 reported
that anesthesia caused the death of a child with ISH who
underwent surgery. Considering the nature of the underly-
ing disease and its guarded prognosis, the risk of anesthesia
and the associated morbidities and complications of a
cardiac operation, we opted not to intervene surgically.
This decision was in accordance with the wishes of the
parents.
In conclusion, this case report highlights the patho-
physiology and the management challenges of comorbid-
ities and complications associated with ISH.Conflicts of interest
The authors have no conflicts of interest to declare.Acknowledgments
The authors extend their appreciation to the College of
Medicine Research Center, Deanship of Scientific Research,
King Saud University (Riyadh, Saudi Arabia) for funding this
work.mic Hyalinosis Complicated with Right Atrial Thrombus and Peri-
//dx.doi.org/10.1016/j.pedneo.2014.01.008
4 S. Mohamed et al
+ MODELReferences
1. McKusick VA. Mendelian Inheritance in Man and its online
version, OMIM. Am J Hum Genet 2007;80:588e604.
2. Al-Mayouf SM, AlMehaidib A, Bahabri S, Shabib S, Sakati N,
Teebi AS. Infantile systemic hyalinosis: a fatal disorder
commonly diagnosed among Arabs. Clin Exp Rheumatol 2005;
23:717e20.
3. Giri PP, Raushan R, Ghosh A, Pal P. Infantile systemic hyali-
nosis. Indian Pediatr 2012;49:62e4.
4. Lindvall LE, Kormeili T, Chen E, Ramirez MC, Grum-Tokars V,
GlucksmanMJ, etal. Infantile systemichyalinosis: case report and
review of the literature. J Am Acad Dermatol 2008;58:303e7.
5. Klebanova Y, Schwindt C. Infantile systemic hyalinosis: a case
report of compromised cellular and humoral branches of the
immune system leading to infections. Pediatr Asthma Allergy
Immunol 2009;22:127e30.
6. Hanks S, Adams S, Douglas J, Arbour L, Atherton DJ, Balci S,
et al. Mutations in the gene encoding capillary morphogenesis
protein 2 cause juvenile hyaline fibromatosis and infantile
systemic hyalinosis. Am J Hum Genet 2003;73:791e800.
7. Wilcox WR. Lysosomal storage disorders: the need for better
pediatric recognition and comprehensive care. J Pediatr 2004;
144:S3e14.
8. Nowlen TT, Rosenthal GL, Johnson GL, Tom DJ, Vargo TA.
Pericardial effusion and tamponade in infants with central
catheters. Pediatrics 2002;110:137e42.Please cite this article in press as: Mohamed S, et al., Infantile Syste
cardial Effusion in an Infant, Pediatrics and Neonatology (2014), http:9. Alkalay AL, Mazkereth R, Santulli Jr T, Pomerance JJ. Central
venous line thrombosis in premature infants: a case manage-
ment and literature review. Am J Perinatol 1993;10:323e6.
10. Arya SO, Hiremath GM, Okonkwo KC, Pettersen MD. Central
venous catheter-associated pericardial tamponade in a 6-day
old: a case report. Int J Pediatr 2009;2009:910208.
11. Darling JC, Newell SJ, Mohamdee O, Uzun O, Cullinane CJ,
Dear PR. Central venous catheter tip in the right atrium: a risk
factor for neonatal cardiac tamponade. J Perinatol 2001;21:
461e4.
12. Onal EE, Saygili A, Koc¸ E, Tu¨rkyilmaz C, Okumus N, Atalay Y.
Cardiac tamponade in a newborn because of umbilical venous
catheterization: is correct position safe? Paediatr Anaesth
2004;14:953e6.
13. Ferrari F, Vagnarelli F, Gargano G, Roversi MF, Biagioni O,
Ranzi A, et al. Early intracardiac thrombosis in preterm in-
fants and thrombolysis with recombinant tissue type plas-
minogen activator. Arch Dis Child Fetal Neonatal Ed 2001;
85:F66e9.
14. Gamillscheg A, Nu¨rnberg JH, Alexi-Meskishvili V, Werner H,
Abdul-Kaliq H, Uhlemann F, et al. Surgical emergency embo-
lectomy for the treatment of fulminant pulmonary embolism in
a preterm infant. J Pediatr Surg 1997;32:1516e8.
15. Pollard M, Ollite EM, Walker RW. The anesthetic management
of a child with infantile systemic hyalinosis. Paediatr Anaesth
2008;18:1123e4.mic Hyalinosis Complicated with Right Atrial Thrombus and Peri-
//dx.doi.org/10.1016/j.pedneo.2014.01.008
